Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
or

Applied Dna Sciences Inc (APDN)

Applied Dna Sciences Inc (APDN)
0.8601 -0.0037 (-0.43%) 16:00 ET [NASDAQ]
0.8501 x 4 0.8756 x 9
Realtime by (Cboe BZX)
0.8501 x 4 0.8756 x 9
Realtime - - (-) -
Quote Overview for Thu, Apr 24th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.8211
Day High
0.9000
Open 0.8573
Previous Close 0.8638 0.8638
Volume 402,738 402,738
Avg Vol 1,562,118 1,562,118
Stochastic %K 14.93% 14.93%
Weighted Alpha -98.21 -98.21
5-Day Change +0.0575 (+7.19%) +0.0575 (+7.19%)
52-Week Range 0.7230 - 253.5000 0.7230 - 253.5000
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 953
  • Shares Outstanding, K 1,104
  • Annual Sales, $ 3,430 K
  • Annual Income, $ -6,990 K
  • EBIT $ -13 M
  • EBITDA $ -13 M
  • 60-Month Beta 0.86
  • Price/Sales 0.29
  • Price/Cash Flow N/A
  • Price/Book 0.08
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -286.00
  • Most Recent Earnings $-28.00 on 02/13/25
  • Next Earnings Date 05/09/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Industrial Products
  • INDUSTRY GROUPING Protection - Safety

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -265.50
  • Growth Rate Est. (year over year) +476.27%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7230 +18.60%
on 04/21/25
Period Open: 2.1200
2.2500 -61.89%
on 03/26/25
-1.2625 (-59.55%)
since 03/24/25
3-Month
0.7230 +18.60%
on 04/21/25
Period Open: 9.2200
9.7150 -91.17%
on 02/11/25
-8.3625 (-90.70%)
since 01/24/25
52-Week
0.7230 +18.60%
on 04/21/25
Period Open: 238.8000
253.5000 -99.66%
on 04/25/24
-237.9425 (-99.64%)
since 04/24/24

Most Recent Stories

More News
Applied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA

- Pivot to U.S.-based Supply Chain for Critical Input Materials Completed -

APDN : 0.8620 (-0.21%)
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement

STONY BROOK, NY / ACCESS Newswire / April 8, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that on April 7, 2025, it received a...

APDN : 0.8620 (-0.21%)
Applied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety Announcement

- Company Revamps Pharmacogenomics Go-To-Market Strategy, Targets Validated PGx Assay Towards Specific Use Cases -

APDN : 0.8620 (-0.21%)
Applied DNA Submits Validation Package to New York State Department of Health for H5 Bird Flu/Pan-Influenza A Laboratory-Developed Test

STONY BROOK, NY / ACCESS Newswire / March 26, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the "Company"), a leader in PCR-based DNA technologies, today announced that Applied DNA Clinical...

APDN : 0.8620 (-0.21%)
Applied DNA Announces 1-For-50 Reverse Stock Split Effective March 14, 2025

STONY BROOK, NY / ACCESS Newswire / March 12, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the "Company"), a leader in PCR-based DNA technologies, today announced that it will effect...

APDN : 0.8620 (-0.21%)
Applied DNA Sciences: Fiscal Q1 Earnings Snapshot

Applied DNA Sciences: Fiscal Q1 Earnings Snapshot

APDN : 0.8620 (-0.21%)
Applied DNA Reports First Quarter Fiscal 2025 Financial Results and Highlights Operational Progress

- Announces Exit of DNA Tagging and Security Products and Services Business Segment -

APDN : 0.8620 (-0.21%)
Applied DNA to Report First Quarter Fiscal 2025 Financial Results After Market Close on Thursday, February 13, 2025

Investor Call and Webcast Scheduled for 4:30 P.M ET

APDN : 0.8620 (-0.21%)
Applied DNA Reminds Shareholders to Vote Ahead of Special Meeting on February 14

STONY BROOK, NY / ACCESS Newswire / February 11, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today issued a reminder to its...

APDN : 0.8620 (-0.21%)
Applied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates

- Signals Start of New Commercialization Phase for LineaRx Subsidiary -

APDN : 0.8620 (-0.21%)

Business Summary

Applied DNA Sciences, Inc. provides proprietary DNA-embedded biotechnology security solutions, using non-human DNA, that verify authenticity and protect corporate and government agencies from counterfeiting, fraud, piracy, product diversion, identity theft and unauthorized intrusion. They develop, market,...

See More

Key Turning Points

3rd Resistance Point 1.0050
2nd Resistance Point 0.9675
1st Resistance Point 0.9156
Last Price 0.8620
1st Support Level 0.8262
2nd Support Level 0.7887
3rd Support Level 0.7368

See More

52-Week High 253.5000
Fibonacci 61.8% 156.9392
Fibonacci 50% 127.1115
Fibonacci 38.2% 97.2838
Last Price 0.8620
52-Week Low 0.7230

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective